21-hydroxylase deficiency MRI: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}} {{AAM}}
{{CMG}} {{AE}} {{AAM}}
==Overview==
==Overview==
On [[MRI]], congenital adrenal hyperplsia is characterized by bilateral symmetric enlargement of [[adrenal glands]].
On [[MRI]], congenital adrenal hyperplsia due to 21-hydroxylase deficiency is characterized by bilateral symmetric enlargement of [[adrenal glands]].
==MRI Findings in Congenital adrenal hyperplasia due to 21-hydroxylase deficiency==
==MRI Findings in Congenital adrenal hyperplasia due to 21-hydroxylase deficiency==
On [[MRI]], congenital adrenal hyperplsia is characterized by bilateral symmetric enlargement of [[adrenal glands]].
On [[MRI]], congenital adrenal hyperplsia due to 21-hydroxylase deficiency is characterized by bilateral symmetric enlargement of [[adrenal glands]].
== References ==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}

Revision as of 13:40, 5 October 2015

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

21-hydroxylase deficiency MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 21-hydroxylase deficiency MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 21-hydroxylase deficiency MRI

CDC on 21-hydroxylase deficiency MRI

21-hydroxylase deficiency MRI in the news

Blogs on 21-hydroxylase deficiency MRI

Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Risk calculators and risk factors for 21-hydroxylase deficiency MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

On MRI, congenital adrenal hyperplsia due to 21-hydroxylase deficiency is characterized by bilateral symmetric enlargement of adrenal glands.

MRI Findings in Congenital adrenal hyperplasia due to 21-hydroxylase deficiency

On MRI, congenital adrenal hyperplsia due to 21-hydroxylase deficiency is characterized by bilateral symmetric enlargement of adrenal glands.

Template:WikiDoc Sources